Guideline-concordant care rate in seniors is approximately 60% after positive lung cancer screen

by Elana GotkineAmong persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant care is 59.7% overall, according to a studypublishedonline D

Family Medicine March 07,2026

Guideline-concordant care rate in seniors is approximately 60% after positive lung cancer screen

by Elana GotkineAmong persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant care is 59.7% overall, according to a studypublishedonline D

Family Medicine March 07,2026

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe

Hematology&Oncology March 07,2026

How to reduce risk of lymphedema after head and neck cancer

by Åsa Hansdotter,Lund UniversityCredit:Oral Oncology(2025). DOI: 10.1016/j.oraloncology.2025.107671Lymphedema after head and neck cancer is considerably more common than previously assumed and can pe

Hematology&Oncology March 07,2026

Stress intensifies pain and makes it harder to regulate emotions in cases of depression and fibromyalgia

by Torsten Lauer,Central Institute of Mental HealthSchematic of EMA and fMRI neurofeedback method. Credit:Pain(2025). DOI: 10.1097/j.pain.0000000000003800A new study led by the Central Institute of Me

Psychiatry & Mental Health March 06,2026

Stress intensifies pain and makes it harder to regulate emotions in cases of depression and fibromyalgia

by Torsten Lauer,Central Institute of Mental HealthSchematic of EMA and fMRI neurofeedback method. Credit:Pain(2025). DOI: 10.1097/j.pain.0000000000003800A new study led by the Central Institute of Me

Psychiatry & Mental Health March 06,2026

Study examines oligodendrocyte dynamics throughout the progression of multiple sclerosis

byIngrid Fadelli, Medical XpressStormy weather: oligodendrocyte dynamics in a mouse model of multiple sclerosis. Castelo-Branco research group, Karolinska Institutet. Credit: Bastien Hervé and Lilian

Neurology March 06,2026

Study examines oligodendrocyte dynamics throughout the progression of multiple sclerosis

byIngrid Fadelli, Medical XpressStormy weather: oligodendrocyte dynamics in a mouse model of multiple sclerosis. Castelo-Branco research group, Karolinska Institutet. Credit: Bastien Hervé and Lilian

Neurology March 06,2026

Glycosylation enzyme selectivity in mouse kidneys shows promise for future disease research

by Institute for Glyco-core Research (iGCORE)Selective modification of substrate by GnT-V in polarized kidney tissue in mice. Credit:iScience(2025). DOI: 10.1016/j.isci.2025.113894Glycans are importan

Family Medicine March 06,2026

Glycosylation enzyme selectivity in mouse kidneys shows promise for future disease research

by Institute for Glyco-core Research (iGCORE)Selective modification of substrate by GnT-V in polarized kidney tissue in mice. Credit:iScience(2025). DOI: 10.1016/j.isci.2025.113894Glycans are importan

Family Medicine March 06,2026

Half of US adults resolve to start a new diet in 2026

by Physicians Committee for Responsible MedicineCredit: Unsplash/CC0 Public DomainNearly half of U.S. adults say starting a new diet is one of their New Year's resolutions, according to a new Phys

Wellness March 06,2026

Half of US adults resolve to start a new diet in 2026

by Physicians Committee for Responsible MedicineCredit: Unsplash/CC0 Public DomainNearly half of U.S. adults say starting a new diet is one of their New Year's resolutions, according to a new Phys

Wellness March 06,2026

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

by Josephine Wright, Susan Woods,The ConversationCredit: CC0 Public DomainBacteria are rapidly emerging as anew classof "living medicines" used to kill cancer cells.We're still a long wa

Hematology&Oncology March 06,2026

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

by Josephine Wright, Susan Woods,The ConversationCredit: CC0 Public DomainBacteria are rapidly emerging as anew classof "living medicines" used to kill cancer cells.We're still a long wa

Hematology&Oncology March 06,2026

Global study finds stable acute kidney injury mortality with shifting age patterns

byAmerican Society of NephrologyCredit: Unsplash/CC0 Public DomainA five-year study has revealed a stability in global acute kidney injury (AKI)–related mortality rates with differing patterns that in

Family Medicine March 05,2026

Global study finds stable acute kidney injury mortality with shifting age patterns

byAmerican Society of NephrologyCredit: Unsplash/CC0 Public DomainA five-year study has revealed a stability in global acute kidney injury (AKI)–related mortality rates with differing patterns that in

Family Medicine March 05,2026

Gluten-free beer may still contain compounds that cause digestive upset

byUniversity of the Basque CountryCredit: CC0 Public DomainThe GLUTEN3S research group of the University of the Basque Country (EHU) has identified the presence of fructans and amylase/trypsin inhibit

Wellness March 05,2026

Gluten-free beer may still contain compounds that cause digestive upset

byUniversity of the Basque CountryCredit: CC0 Public DomainThe GLUTEN3S research group of the University of the Basque Country (EHU) has identified the presence of fructans and amylase/trypsin inhibit

Wellness March 05,2026

How colorectal cancer evades immunotherapy using a dual barrier

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Pixabay/CC0 Public DomainColorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treat

Hematology&Oncology March 05,2026

How colorectal cancer evades immunotherapy using a dual barrier

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Pixabay/CC0 Public DomainColorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treat

Hematology&Oncology March 05,2026